Trial intelligence / Profile preview

Basal Insulin in DKA Management

NCT00590044Phase 4Completed

Sponsor
Emory University
Start
Dec 2007
Primary completion
Jun 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin glargine in diabetic ketoacidosis (DKA), sponsored by Emory University. Started Dec 2007; status: completed.

02

Drugs

insulin glargine
03

Conditions

diabetic ketoacidosis (DKA)

Beyond the preview

Go deeper on NCT00590044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00590044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call